Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant (TA64) - guidance

Treosulfan with fludarabine is recommended as an option for conditioning treatment before allogeneic haematopoietic stem cell transplant for people with malignant diseases for whom a reduced intensity regimen, such as low-dose busulfan with fludarabine, would be suitable.


National Institute for Health and Care Excellence